HTBX Heat Biologics Receives Green Light to Expand Enrollment of Its Phase 1/2 Study of HS-410 in Bladder Cancer Based on Encouraging Preliminary Safety Results http://finance.yahoo.com/news/heat-biologics-receives-green-light-120500050.html?soc_src=mediacontentstory stockcharts.com/c-sc/sc?s=HTBX&p=D&b=5&g=0&i=p24424704884&r=1401456007865